Advanced Medical Equipment

Advanced Medical Equipment EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of Advanced Medical Equipment (AME.WA) as of Nov 22, 2026 is 31,746.79. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was 101,431.67 — a change of -68.70% (lower).

EV/EBITDA

31,746.79

YoY

-68.70%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of Advanced Medical Equipment is 2024 31,746.79 . EV/EBITDA (Enterprise Value to EBITDA) of Advanced Medical Equipment was 2023 101,431.67 . It decreases by -68.70% lower compared to the previous year.

The Advanced Medical Equipment EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2023
101,431.67 PLN
Jan 1, 2024
31,746.79 PLN
The Advanced Medical Equipment EV/EBITDA history
YEAREV/EBITDAYoY
31,746.79-68.70%
101,431.67—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Advanced Medical Equipment Stock analysis

What does Advanced Medical Equipment do? Advanced Medical Equipment SA generates revenue through the sale of its innovative Diabetomat device, which measures diabetes biomarkers in exhaled air without pain or anxiety. The device is internationally recognized as a noninvasive solution for over 600 million people globally, targeting patients and healthcare providers seeking advanced diabetes management tools. The company operates in the Health Care Equipment & Supplies industry with a focus on Poland-based medical technology development and distribution. The firm's primary product, Diabetomat, serves a global market segment of diabetes patients and healthcare professionals, eliminating the need for traditional invasive blood glucose monitoring. As a Poland-based company headquartered in Warsaw, it leverages its scientific recognition to market the device internationally, capitalizing on the growing demand for noninvasive medical technologies in the healthcare sector. Advanced Medical Equipment is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Advanced Medical Equipment stock

EV/EBITDA (Enterprise Value to EBITDA) of Advanced Medical Equipment is 31,746.79 in 2024.

EV/EBITDA (Enterprise Value to EBITDA) of Advanced Medical Equipment changed from 101,431.67 to 31,746.79, representing a -68.70% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) Advanced Medical Equipment since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s Advanced Medical Equipment with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Advanced Medical Equipment

All Key Metrics — Advanced Medical Equipment